bioAffinity Technologies
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 75
- Market Cap
- $21.7M
- Introduction
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay
- Conditions
- Lung Cancer
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- bioAffinity Technologies Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05870592
- Locations
- 🇺🇸
Brooke Army Medical Hospital, San Antonio, Texas, United States
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- bioAffinity Technologies Inc.
- Target Recruit Count
- 197
- Registration Number
- NCT03837600
- Locations
- 🇺🇸
Radiology Associates of Albuquerque, Albuquerque, New Mexico, United States
🇺🇸Waterbury Pulmonary Associates LLC, Waterbury, Connecticut, United States
🇺🇸Meridian Health, Neptune, New Jersey, United States
Collection of Sputum and Labeling for Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- bioAffinity Technologies Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT03457415
- Locations
- 🇺🇸
South Texas Veterans Health Care System (STVHCS)/Audie L. Murphy Memorial Veterans Hospital, San Antonio, Texas, United States
🇺🇸Atlantic Respiratory Institute, Summit, New Jersey, United States
🇺🇸Radiology Associates of Albuquerque, Albuquerque, New Mexico, United States
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Device: CyPath®
- First Posted Date
- 2015-03-13
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- bioAffinity Technologies Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT02388074
- Locations
- 🇺🇸
Radiology Associates of Albuquerque (RAA), Albuquerque, New Mexico, United States